AC
IMUX icon

AWH Capital’s Immunic IMUX Stock Holding History

AWH Capital’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50,000
Closed -$745K – 29
2023
Q1 		$745K Hold
50,000
– – 0.76% 26
2022
Q4 		$700K Buy
+50,000
New +$1.36M 0.87% 22

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

AWH Capital's IMUX Position: Q2 2023 in Review

AWH Capital sold out of Immunic (IMUX) in Q2 2023, closing a stake of 50,000 shares — an estimated $745K sold.

AWH Capital first reported a position in IMUX in Q4 2022 and held it in 2 quarters. The position peaked at $745K in Q1 2023. 63 funds tracked by Wall St. Rank hold IMUX as of Q2 2023.

  • AWH Capital reported no remaining Immunic position as of Q2 2023 after selling out during the quarter.
  • AWH Capital sold 50,000 Immunic shares in Q2 2023, an estimated $745K.
  • AWH Capital first reported a position in Immunic in Q4 2022 and held it in 2 quarters.
  • AWH Capital's Immunic position peaked at $745K in Q1 2023.
  • 63 funds tracked by Wall St. Rank held Immunic as of Q2 2023.

Based on AWH Capital's 13F filing for Q2 2023, filed 14 Aug 2023.